Gout: diagnosis and management

You can now review and comment on this draft guideline.

The consultation closes at 5pm on Wednesday 2nd February 2022

How to comment

1. Register your organisation or comment as an individual

If you’re commenting for an organisation, your organisation needs to be registered as a stakeholder.

Not eligible? Contact the stakeholder organisation that most closely represents your interests and pass your comments to them.

We can accept comments from individuals. These will be considered, but you won’t get a formal response and they won’t be posted on the NICE website. Wherever possible we encourage you to submit your comments through a registered stakeholder organisation.

2. Read the consultation documents

Documents to comment on:

• Draft guideline – just the recommendations

Evidence reviews

• Evidence review A - Patient information
• Evidence review B - Signs and symptoms
• Evidence review C - Gout diagnosis approach
• Evidence review D - Management of gout flares
• Evidence review E - Which patients should be selected for ULT
• Evidence review F - ULT timing
• Evidence review G - Urate lowering therapies for the long-term management of gout
• Evidence review H - Pharma prevention
• Evidence review I - Diet and lifestyle
• Evidence review J - Treat to target management
• Evidence review K - Best serum urate level target
• Evidence review L - Optimum frequency of monitoring
• Evidence review M - Follow-up for flares
• Evidence review N - Referral to specialist
• Evidence review O - Surgical excision of tophi

Supplementary Documents

• Methods
• Appendix 1 - Gout multimorbidity project
• NGC Acknowledgement
• Economic model report
• Economic model

If you want to review the economic model, please see 5. Economic models below and fill in the confidentiality form.

Other information about the consultation

• Equality impact assessment
• Committee membership list
• Developing NICE guidelines: how to get involved

3. Add your comments

• You must use this comments form.
• You must declare any links with, or funding from, the tobacco industry

If you share similar views with another organisation, send a joint response.

Make sure you consider:

• The areas that will have the biggest impact on practice and be challenging to implement
• How to help users overcome challenges

Developing NICE guidelines: how to get involved suggests some other areas to comment on.

4. Email the form to us

Email: ManagementOfGout@nice.org.uk

Deadline: 5pm on Wednesday 2nd February 2022

5. Economic model

The developer has produced an economic model to support the guideline on Gout: diagnosis and management. To receive an executable version of this model, please submit a request to ManagementOfGout@nice.org.uk with a signed copy of the confidentiality acknowledgement and undertaking form.

We will then send you a link to an executable version of the economic model by email. The deadline for returning your comments is the same as for the guideline consultation: 5pm on 02 February 2022.